EGFR molecular testing in African-American non-small cell lung cancer patients - a review of discrepant data

Por Clifford, Bradley T., Fu, Pingfu, Pennell, Nathan A., Halmos, Balazs, Leidner, Rom S.
Publicado no Transl Lung Cancer Res (2013)

AZD9291 in TKI EGFR resistance in non-small cell lung cancer and the new concept of phase I trials

Por Gil-Bazo, Ignacio, Rolfo, Christian
Publicado no Transl Lung Cancer Res (2016)

PGE(2) contributes to TGF-β induced T regulatory cell function in human non-small cell lung cancer

Por Baratelli, Felicita, Lee, Jay M, Hazra, Saswati, Lin, Ying, Walser, Tonya C, Schaue, Dorthe, Pak, Peter S, Elashoff, David, Reckamp, Karen, Zhang, Ling, Fishbein, Michael C, Sharma, Sherven, Dubinett, Steven M
Publicado em 2010

Elevated serum annexin A1 as potential diagnostic marker for lung cancer: a retrospective case-control study

Por Rong, Biaoxue, Zhao, Chongchong, Liu, Hua, Ming, Zongjuan, Cai, Xiguang, Gao, Wenlong, Yang, Shuanying
Publicado em 2014

Anatomic, functional and molecular imaging in lung cancer precision radiation therapy: treatment response assessment and radiation therapy personalization

Por MacManus, Michael, Everitt, Sarah, Schimek-Jasch, Tanja, Li, X. Allen, Nestle, Ursula, Kong, Feng-Ming (Spring)
Publicado no Transl Lung Cancer Res (2017)

Clinicopathologic characteristics of patients with ROS1 fusion gene in non-small cell lung cancer: a meta-analysis

Por Zhu, Qingqing, Zhan, Ping, Zhang, Xinlin, Lv, Tangfeng, Song, Yong
Publicado no Transl Lung Cancer Res (2015)

LAT1 expression is closely associated with hypoxic markers and mTOR in resected non-small cell lung cancer

Por Kaira, Kyoichi, Oriuchi, Noboru, Takahashi, Toshiaki, Nakagawa, Kazuo, Ohde, Yasuhisa, Okumura, Takehiro, Murakami, Haruyasu, Shukuya, Takehito, Kenmotsu, Hirotsugu, Naito, Tateaki, Kanai, Yoshikatsu, Endo, Masahiro, Kondo, Haruhiko, Nakajima, Takashi, Yamamoto, Nobuyuki
Publicado em 2011

The crosstalk between β-catenin signaling and type I, type II and type III interferons in lung cancer cells

Por Bai, Ming, Li, Wei, Yu, Nanze, Zhang, Hailin, Long, Fei, Zeng, Ang
Publicado no Am J Transl Res (2017)

Stereotactic body radiotherapy as salvage treatment for recurrence of non-small cell lung cancer after prior surgery or radiotherapy

Por Milano, Michael T., Kong, Feng-Ming (Spring), Movsas, Benjamin
Publicado no Transl Lung Cancer Res (2019)

A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer

Por Komiya, Takefumi, Memmott, Regan M., Blumenthal, Gideon M., Bernstein, Wendy, Ballas, Marc S., De Chowdhury, Roopa, Chun, Guinevere, Peer, Cody J., Figg, William D., Liewehr, David J., Steinberg, Seth M., Giaccone, Giuseppe, Szabo, Eva, Kawabata, Shigeru, Tsurutani, Junji, Rajan, Arun, Dennis, Phillip A.
Publicado no Transl Lung Cancer Res (2019)

Advanced proton beam dosimetry part II: Monte Carlo vs. pencil beam-based planning for lung cancer

Por Maes, Dominic, Saini, Jatinder, Zeng, Jing, Rengan, Ramesh, Wong, Tony, Bowen, Stephen R.
Publicado no Transl Lung Cancer Res (2018)

P24. Epidemiologic, clinical characteristics of elderly non-small lung cancer patients treated in a single institution

Por Vaslamatzis, Michail, Alevizopoulos, Nektarios, Tegos, Theodoros, Zoublios, Charalambos, Kapou, Theodora, Kyriou, Lambrini, Stathopoulos, Charalambos, Gkoumas, Georgios, Patila, Elisavet, Delaki, Aikaterini
Publicado no Transl Lung Cancer Res (2014)

Durvalumab for non-resectable stage IIIB non-small cell lung cancer—a small step or a big leap?

Por Dempke, Wolfram C. M., Fenchel, Klaus
Publicado no Transl Lung Cancer Res (2018)

Recent advances in the development of mutant-selective EGFR inhibitors for non-small cell lung cancer patients with EGFR-TKI resistance

Por Luo, Yung-Hung, Chen, Yuh-Min
Publicado no Transl Lung Cancer Res (2014)

Combination MET- and EGFR-directed therapy in MET-overexpressing non-small cell lung cancers: time to move on to better biomarkers?

Por Santini, Fernando C., Kunte, Siddharth, Drilon, Alexander
Publicado no Transl Lung Cancer Res (2017)

The evolving first-line treatment of advanced non-small cell lung cancer harbouring epidermal growth factor receptor mutations

Por Decoster, Lore, Giron, Philippe, Mignon, Sacha, De Grève, Jacques
Publicado no Transl Lung Cancer Res (2018)

Post-operative radiation therapy in locally advanced non-small cell lung cancer and the impact of sequential versus concurrent chemotherapy

Por Waddle, Mark R., Ko, Stephen, Johnson, Margaret M., Lou, Yanyan, Miller, Robert C., Harrell, Anna C., Trifiletti, Daniel M.
Publicado no Transl Lung Cancer Res (2018)

Erlotinib plus concurrent whole-brain radiation therapy for non-small cell lung cancers patients with multiple brain metastases

Por Ulahannan, Danny, Lee, Siow-Ming
Publicado no Transl Lung Cancer Res (2016)

Insulin-like growth factor-1 receptor-targeted therapy for non-small cell lung cancer: a mini review

Por Yin, Ming, Guan, Xiaoxiang, Liao, Zhongxin, Wei, Qingyi
Publicado em 2009

Prognostic and predictive biomarkers in early stage non-small cell lung cancer: tumor based approaches including gene signatures

Por Carnio, Simona, Novello, Silvia, Papotti, Mauro, Loiacono, Marco, Scagliotti, Giorgio Vittorio
Publicado no Transl Lung Cancer Res (2013)